Search results
Eli Lilly wants to replace Zepbound with an even stronger weight loss drug
Quartz· 1 hour agoSkyrocketing sales of tirzepatide — the active ingredient in Mounjaro and Zepbound — transformed Eli...
10 Reasons to Buy Eli Lilly Stock Now
247wallst.com· 4 hours agoOne such company that’s now increasingly viewed as a growth play is Eli Lilly (NYSE: LLY). With this in mind, let’s dive into the top 10 reasons...
Ask Eli: When do you pay capital gains tax on property sale? | ARLnow.com
ARLnow.com· 3 days agoThis regularly scheduled sponsored Q&A column is written by Eli Tucker, Arlington-based Realtor and...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 3 hours agoThis week, an FDA advisory committee unanimously recommended approval of Eli Lilly’s LLY Alzheimer's...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 4 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Stock Market Hits Highs; Tame Inflation, Fed Meeting, Apple, Broadcom, Oracle, Tesla: Weekly Review
Investor's Business Daily· 2 hours agoApple surged to a record high as it laid out its long-awaited AI strategy. Oracle and Broadcom...
Wegovy's Precarious Position: 3 Drugs Most Likely to Dethrone Novo Nordisk's Blockbuster Obesity...
Motley Fool via Yahoo Finance· 6 hours agoBut note the use of the word "currently." Wegovy's market-topping position is precarious. Here are...
Eli Lilly pharma company debuts new Concord digs with Gov. Cooper on hand
WJZY via Yahoo Finance· 4 hours agoCONCORD, N.C. (QUEEN CITY NEWS) – North Carolina Governor Roy Cooper is in Concord Friday for the...
Caitlin Clark Blocks Boy's Shot as They Play Basketball at Charity Event — and He's Adorably...
People Magazine· 19 hours agoCaitlin Clark didn’t pull any punches when she faced a 7-year-old opponent earlier this week. The...
Here's Why Eli Lilly Will Likely Announce a Stock Split
247wallst.com· 3 days agoWith its stock price fast approaching $1000 per share, drugmakerEli lilly is poised for a forward...